Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H25N3O2 |
Molecular Weight | 303.3993 |
Optical Activity | ( - ) |
Defined Stereocenters | 1 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N4CCC[C@H]4C#N
InChI
InChIKey=SYOKIDBDQMKNDQ-XWTIBIIYSA-N
InChI=1S/C17H25N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h12-14,19,22H,1-8,10-11H2/t12?,13?,14-,16?,17?/m0/s1
Molecular Formula | C17H25N3O2 |
Molecular Weight | 303.3993 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:31:32 UTC 2023
by
admin
on
Fri Dec 15 15:31:32 UTC 2023
|
Record UNII |
I6B4B2U96P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C98086
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
||
|
WHO-ATC |
A10BD08
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
||
|
WHO-VATC |
QA10BD08
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
||
|
WHO-VATC |
QA10BH02
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
||
|
WHO-ATC |
A10BH02
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
RR-71
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
596554
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | RxNorm | ||
|
DB04876
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
DTXSID80881091
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
I6B4B2U96P
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
CHEMBL142703
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
274901-16-5
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
C66653
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
3642
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
SUB25199
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
8399
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
VILDAGLIPTIN
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
6310
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
C502012
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
m11447
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000089156
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY | |||
|
6918537
Created by
admin on Fri Dec 15 15:31:32 UTC 2023 , Edited by admin on Fri Dec 15 15:31:32 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
EXCRETED UNCHANGED |
FECAL
|
||
|
BINDER->LIGAND |
The mean plasma protein binding of vildagliptin in humans was low (9.3%) and also independent of concentration.
BINDING
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
EXCRETED UNCHANGED |
URINE
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
PLASMA
|
||
|
METABOLITE -> PARENT |
FECAL
|
||
|
METABOLITE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
FECAL
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
MAJOR
PLASMA
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
PLASMA
|
||
|
METABOLITE -> PARENT |
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
Biological Half-life | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||